Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 4 of 4

Full-Text Articles in Medicine and Health Sciences

Tumor-Derived Interleukin-10 As A Prognostic Factor In Stage Iii Patients Undergoing Adjuvant Treatment With An Autologous Melanoma Cell Vaccine., Amit Mahipal, Mizue Terai, David Berd, Inna Chervoneva, Kashyap Patel, Michael Mastrangelo, Takami Sato Jul 2011

Tumor-Derived Interleukin-10 As A Prognostic Factor In Stage Iii Patients Undergoing Adjuvant Treatment With An Autologous Melanoma Cell Vaccine., Amit Mahipal, Mizue Terai, David Berd, Inna Chervoneva, Kashyap Patel, Michael Mastrangelo, Takami Sato

Department of Medical Oncology Faculty Papers

OBJECTIVES: Interleukin-10 (IL-10) downregulates T-cell-mediated immune responses. We studied the association between IL-10 production by freshly isolated melanoma cell suspensions in vitro and overall survival in patients undergoing adjuvant treatment with a vaccine prepared from the same autologous melanoma cells modified with a hapten, dinitrophenyl (DNP).

METHODS: Forty-four patients with cutaneous melanoma (29 stage III and 15 stage IV) were prospectively evaluated. Tumor cells were extracted from metastatic deposits for production of DNP-modified autologous melanoma cell vaccine. Small aliquots of the melanoma cell suspensions were separated prior to vaccine processing and cultured overnight for IL-10 production. Based on a blind …


Oncolog, Volume 56, Number 06, June 2011, John H. Mccool, Sunni Hoseman Jun 2011

Oncolog, Volume 56, Number 06, June 2011, John H. Mccool, Sunni Hoseman

OncoLog MD Anderson's Report to Physicians (All issues)

  • MD Anderson Celebrates 70th Anniversary: Its first clinical facility was a converted Army barracks, its first headquarters was renovated residential estate near downtown Houston, and its first cancer research was conducted by four scientists in a former horse stable
  • Compass: Stage II or III Soft Tissue Sarcoma-Chemotherapy and radiation therapy before or after surgery benefit patients


Oncolog, Volume 56, Number 04-05, April-May 2011, Zach Bohannan, Bryan Tutt Apr 2011

Oncolog, Volume 56, Number 04-05, April-May 2011, Zach Bohannan, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

  • Understanding and Managing Multiple Endocrine Neoplasia Syndromes: Endocrine tumors caused by multiple endocrine neoplasia syndromes (MEN) pose a dual threat-both from the tumors' potential for growth or metastasis and from their hormonal secretions
  • Two-Stage Resection and Improved Chemotherapy Regimens Lengthen Survival for Patients with Lever Metastasis from Colorectal Cancer
  • HOUSE CALL: Saving a Life by Donating Stem Cells: Fact about stem cell transplants
  • IN BRIEF: Study Reveals How EZH2 Protein Promotes Breast Tumor-Initiating Cell Growth


Oncolog, Volume 56, Number 03, March 2011, Bryan Tutt, Joe Munch Mar 2011

Oncolog, Volume 56, Number 03, March 2011, Bryan Tutt, Joe Munch

OncoLog MD Anderson's Report to Physicians (All issues)

  • Glioblastoma Cure Remains Elusive Despite Treatment Advances: Aggressive surgery followed by radiation therapy and chemo-therapy offers hope of long-term survival for some patients with glioblastoma, but for most glioblastoma patients, the prognosis is poor
  • Assessing and Addressing the Biological Effects of Stress in Cancer Patients: Stress has long been linked to cancer progression. But the precise mechanisms by which stress exacts its pro-tumor effects are not fully understood
  • MD Anderson One of Four Centers to Test Cancer Cell Detection Chip: A new test that could monitor the effectiveness of cancer treatment
  • HOUSE CALL: Yoga and Tai Chi: Two distinct disciplines …